25133 A single-center, open-label clinical trial evaluated the efficacy and tolerability of a comprehensive, hydrating topical antioxidant developed specifically for men.

MLA

Sikora, Brooke C., et al. “25133 A Single-Center, Open-Label Clinical Trial Evaluated the Efficacy and Tolerability of a Comprehensive, Hydrating Topical Antioxidant Developed Specifically for Men.” Journal of the American Academy of Dermatology, vol. 85, no. 3, Sept. 2021, p. AB53. EBSCOhost, https://doi.org/10.1016/j.jaad.2021.06.238.

APA

Sikora, B. C., Dover, J. S., Wortzman, M., & Nelson, D. B. (2021). 25133 A single-center, open-label clinical trial evaluated the efficacy and tolerability of a comprehensive, hydrating topical antioxidant developed specifically for men. Journal of the American Academy of Dermatology, 85(3), AB53. https://doi.org/10.1016/j.jaad.2021.06.238

Chicago

Sikora, Brooke C., Jeffrey S. Dover, Mitchell Wortzman, and Diane B. Nelson. 2021. “25133 A Single-Center, Open-Label Clinical Trial Evaluated the Efficacy and Tolerability of a Comprehensive, Hydrating Topical Antioxidant Developed Specifically for Men.” Journal of the American Academy of Dermatology 85 (3): AB53. doi:10.1016/j.jaad.2021.06.238.